Currently out of the existing stock ratings of Dane Leone, 119 are a BUY (80.95%), 26 are a HOLD (17.69%), 2 are a SELL (1.36%).

Dane Leone

Work Performance Price Targets & Ratings Chart

Analyst Dane Leone, carries an average stock price target met ratio of 52.52% that have a potential upside of 29.92% achieved within 221 days. Previously, Dane Leone worked at RAYMOND JAMES, BTIG.

Dane Leone’s has documented 249 price targets and ratings displayed on 38 stocks. The coverage was on Healthcare, Technology, Energy, Consumer Cyclical sectors.

Most recent stock forecast was given on XLO, Xilio Development at 08-Nov-2024.

Wall Street Analyst Dane Leone

Analyst best performing recommendations are on NKTX (NKARTA ).
The best stock recommendation documented was for TARS (TARSUS PHARMACEUTICALS ) at 11/10/2020. The price target of $39 was fulfilled within 34 days with a profit of $17.81 (84.05%) receiving and performance score of 24.72.

Average potential price target upside

ADVM Adverum Biotechnologies ALLO Allogene Therapeutics BLUE Bluebird bio BPMC Blueprint Medicines Corp CYTK Cytokinetics GTHX G1 Therapeutics OCUL Ocular Therapeutix REGN Regeneron Pharmaceuticals RGNX Regenxbio SAGE Sage Therapeutic SLP Simulations Plus TARS Tarsus Pharmaceuticals  BRKR Bruker GLPG Galapagos NV ADR BMY Bristol-Myers Squibb Company CRIS Curis NKTX Nkarta  CMPX Compass Therapeutics XNCR Xencor SGEN Seagen AMGN Amgen AYLA Ayala Pharmaceuticals  BBIO BridgeBio Pharma JNJ Johnson & Johnson LIAN LianBio ADR RLAY Relay Therapeutics  VYGR Voyager Therapeutics XLO Xilio Development ALR Alerislife CELG Celgene ILMN Illumina MGNX MacroGenics BL Blackline BP BP PLC ADR LI Li Auto  MGTA Magenta Therapeutics SA Seabridge Gold TMO Thermo Fisher Scientific

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Nov-2023

$5.5

$1.14 (26.15%)

$12

Hold Since 16-Apr-2025

$4

$-0.36 (-8.26%)

$5

Hold Since 19-Mar-2024

$4

$-0.36 (-8.26%)

$5

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Dane Leone?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?